BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 22502944)

  • 1. Exome sequencing of prostate cancer supports the hypothesis of independent tumour origins.
    Lindberg J; Klevebring D; Liu W; Neiman M; Xu J; Wiklund P; Wiklund F; Mills IG; Egevad L; Grönberg H
    Eur Urol; 2013 Feb; 63(2):347-53. PubMed ID: 22502944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline mutations in candidate predisposition genes in individuals with cutaneous melanoma and at least two independent additional primary cancers.
    Pritchard AL; Johansson PA; Nathan V; Howlie M; Symmons J; Palmer JM; Hayward NK
    PLoS One; 2018; 13(4):e0194098. PubMed ID: 29641532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mate pair sequencing of whole-genome-amplified DNA following laser capture microdissection of prostate cancer.
    Murphy SJ; Cheville JC; Zarei S; Johnson SH; Sikkink RA; Kosari F; Feldman AL; Eckloff BW; Karnes RJ; Vasmatzis G
    DNA Res; 2012 Oct; 19(5):395-406. PubMed ID: 22991452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accurate quantification of copy-number aberrations and whole-genome duplications in multi-sample tumor sequencing data.
    Zaccaria S; Raphael BJ
    Nat Commun; 2020 Sep; 11(1):4301. PubMed ID: 32879317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The genomic evolution of human prostate cancer.
    Mitchell T; Neal DE
    Br J Cancer; 2015 Jul; 113(2):193-8. PubMed ID: 26125442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HATCHet2: clone- and haplotype-specific copy number inference from bulk tumor sequencing data.
    Myers MA; Arnold BJ; Bansal V; Balaban M; Mullen KM; Zaccaria S; Raphael BJ
    Genome Biol; 2024 May; 25(1):130. PubMed ID: 38773520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diverse heterogeneity of molecular alterations in prostate cancer identified through next-generation sequencing.
    Wyatt AW; Mo F; Wang Y; Collins CC
    Asian J Androl; 2013 May; 15(3):301-8. PubMed ID: 23503423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic DNA copy number alterations and their potential clinical utility for predicting lethal prostate cancer.
    Liu W; Wang L; Xu J
    Asian J Androl; 2013 Sep; 15(5):586-7. PubMed ID: 23817503
    [No Abstract]   [Full Text] [Related]  

  • 9. Experimental and bioinformatics considerations in cancer application of single cell genomics.
    Tan JHJ; Kong SL; Tai JA; Poh HM; Yao F; Sia YY; Lim EKH; Takano AM; Tan DS; Javed A; Hillmer AM
    Comput Struct Biotechnol J; 2021; 19():343-354. PubMed ID: 33489004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mutational landscape of lethal castration-resistant prostate cancer.
    Grasso CS; Wu YM; Robinson DR; Cao X; Dhanasekaran SM; Khan AP; Quist MJ; Jing X; Lonigro RJ; Brenner JC; Asangani IA; Ateeq B; Chun SY; Siddiqui J; Sam L; Anstett M; Mehra R; Prensner JR; Palanisamy N; Ryslik GA; Vandin F; Raphael BJ; Kunju LP; Rhodes DR; Pienta KJ; Chinnaiyan AM; Tomlins SA
    Nature; 2012 Jul; 487(7406):239-43. PubMed ID: 22722839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer.
    Barbieri CE; Baca SC; Lawrence MS; Demichelis F; Blattner M; Theurillat JP; White TA; Stojanov P; Van Allen E; Stransky N; Nickerson E; Chae SS; Boysen G; Auclair D; Onofrio RC; Park K; Kitabayashi N; MacDonald TY; Sheikh K; Vuong T; Guiducci C; Cibulskis K; Sivachenko A; Carter SL; Saksena G; Voet D; Hussain WM; Ramos AH; Winckler W; Redman MC; Ardlie K; Tewari AK; Mosquera JM; Rupp N; Wild PJ; Moch H; Morrissey C; Nelson PS; Kantoff PW; Gabriel SB; Golub TR; Meyerson M; Lander ES; Getz G; Rubin MA; Garraway LA
    Nat Genet; 2012 May; 44(6):685-9. PubMed ID: 22610119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spatial genomic heterogeneity within localized, multifocal prostate cancer.
    Boutros PC; Fraser M; Harding NJ; de Borja R; Trudel D; Lalonde E; Meng A; Hennings-Yeomans PH; McPherson A; Sabelnykova VY; Zia A; Fox NS; Livingstone J; Shiah YJ; Wang J; Beck TA; Have CL; Chong T; Sam M; Johns J; Timms L; Buchner N; Wong A; Watson JD; Simmons TT; P'ng C; Zafarana G; Nguyen F; Luo X; Chu KC; Prokopec SD; Sykes J; Dal Pra A; Berlin A; Brown A; Chan-Seng-Yue MA; Yousif F; Denroche RE; Chong LC; Chen GM; Jung E; Fung C; Starmans MH; Chen H; Govind SK; Hawley J; D'Costa A; Pintilie M; Waggott D; Hach F; Lambin P; Muthuswamy LB; Cooper C; Eeles R; Neal D; Tetu B; Sahinalp C; Stein LD; Fleshner N; Shah SP; Collins CC; Hudson TJ; McPherson JD; van der Kwast T; Bristow RG
    Nat Genet; 2015 Jul; 47(7):736-45. PubMed ID: 26005866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mitochondrial and autosomal mutation landscapes of prostate cancer.
    Lindberg J; Mills IG; Klevebring D; Liu W; Neiman M; Xu J; Wikström P; Wiklund P; Wiklund F; Egevad L; Grönberg H
    Eur Urol; 2013 Apr; 63(4):702-8. PubMed ID: 23265383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrative clinical genomics of advanced prostate cancer.
    Robinson D; Van Allen EM; Wu YM; Schultz N; Lonigro RJ; Mosquera JM; Montgomery B; Taplin ME; Pritchard CC; Attard G; Beltran H; Abida W; Bradley RK; Vinson J; Cao X; Vats P; Kunju LP; Hussain M; Feng FY; Tomlins SA; Cooney KA; Smith DC; Brennan C; Siddiqui J; Mehra R; Chen Y; Rathkopf DE; Morris MJ; Solomon SB; Durack JC; Reuter VE; Gopalan A; Gao J; Loda M; Lis RT; Bowden M; Balk SP; Gaviola G; Sougnez C; Gupta M; Yu EY; Mostaghel EA; Cheng HH; Mulcahy H; True LD; Plymate SR; Dvinge H; Ferraldeschi R; Flohr P; Miranda S; Zafeiriou Z; Tunariu N; Mateo J; Perez-Lopez R; Demichelis F; Robinson BD; Schiffman M; Nanus DM; Tagawa ST; Sigaras A; Eng KW; Elemento O; Sboner A; Heath EI; Scher HI; Pienta KJ; Kantoff P; de Bono JS; Rubin MA; Nelson PS; Garraway LA; Sawyers CL; Chinnaiyan AM
    Cell; 2015 May; 161(5):1215-1228. PubMed ID: 26000489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Punctuated evolution of prostate cancer genomes.
    Baca SC; Prandi D; Lawrence MS; Mosquera JM; Romanel A; Drier Y; Park K; Kitabayashi N; MacDonald TY; Ghandi M; Van Allen E; Kryukov GV; Sboner A; Theurillat JP; Soong TD; Nickerson E; Auclair D; Tewari A; Beltran H; Onofrio RC; Boysen G; Guiducci C; Barbieri CE; Cibulskis K; Sivachenko A; Carter SL; Saksena G; Voet D; Ramos AH; Winckler W; Cipicchio M; Ardlie K; Kantoff PW; Berger MF; Gabriel SB; Golub TR; Meyerson M; Lander ES; Elemento O; Getz G; Demichelis F; Rubin MA; Garraway LA
    Cell; 2013 Apr; 153(3):666-77. PubMed ID: 23622249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue.
    Cooper CS; Eeles R; Wedge DC; Van Loo P; Gundem G; Alexandrov LB; Kremeyer B; Butler A; Lynch AG; Camacho N; Massie CE; Kay J; Luxton HJ; Edwards S; Kote-Jarai Z; Dennis N; Merson S; Leongamornlert D; Zamora J; Corbishley C; Thomas S; Nik-Zainal S; O'Meara S; Matthews L; Clark J; Hurst R; Mithen R; Bristow RG; Boutros PC; Fraser M; Cooke S; Raine K; Jones D; Menzies A; Stebbings L; Hinton J; Teague J; McLaren S; Mudie L; Hardy C; Anderson E; Joseph O; Goody V; Robinson B; Maddison M; Gamble S; Greenman C; Berney D; Hazell S; Livni N; ; Fisher C; Ogden C; Kumar P; Thompson A; Woodhouse C; Nicol D; Mayer E; Dudderidge T; Shah NC; Gnanapragasam V; Voet T; Campbell P; Futreal A; Easton D; Warren AY; Foster CS; Stratton MR; Whitaker HC; McDermott U; Brewer DS; Neal DE
    Nat Genet; 2015 Apr; 47(4):367-372. PubMed ID: 25730763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tracking the origin of metastatic prostate cancer.
    Lindberg J; Kristiansen A; Wiklund P; Grönberg H; Egevad L
    Eur Urol; 2015 May; 67(5):819-22. PubMed ID: 25246081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of exome sequencing to estimate tumor burden in plasma.
    Klevebring D; Neiman M; Sundling S; Eriksson L; Darai Ramqvist E; Celebioglu F; Czene K; Hall P; Egevad L; Grönberg H; Lindberg J
    PLoS One; 2014; 9(8):e104417. PubMed ID: 25133800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence.
    Genovese G; Kähler AK; Handsaker RE; Lindberg J; Rose SA; Bakhoum SF; Chambert K; Mick E; Neale BM; Fromer M; Purcell SM; Svantesson O; Landén M; Höglund M; Lehmann S; Gabriel SB; Moran JL; Lander ES; Sullivan PF; Sklar P; Grönberg H; Hultman CM; McCarroll SA
    N Engl J Med; 2014 Dec; 371(26):2477-87. PubMed ID: 25426838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity in the inter-tumor transcriptome of high risk prostate cancer.
    Wyatt AW; Mo F; Wang K; McConeghy B; Brahmbhatt S; Jong L; Mitchell DM; Johnston RL; Haegert A; Li E; Liew J; Yeung J; Shrestha R; Lapuk AV; McPherson A; Shukin R; Bell RH; Anderson S; Bishop J; Hurtado-Coll A; Xiao H; Chinnaiyan AM; Mehra R; Lin D; Wang Y; Fazli L; Gleave ME; Volik SV; Collins CC
    Genome Biol; 2014 Aug; 15(8):426. PubMed ID: 25155515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.